Status:
ENROLLING_BY_INVITATION
Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely
Lead Sponsor:
NeuraLight
Collaborating Sponsors:
Hospitales Universitarios Virgen del Rocío
Conditions:
Parkinson Disease
Progressive Supranuclear Palsy(PSP)
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
This is an observational longitudinal study in 4 cohorts of patients with Parkinsonian syndromes, who are visiting the Movement Disorders outpatient clinics. The aim of the study is to assess the dif...
Detailed Description
As a part of the study, about 40 subjects will undergo a neurological evaluation including motor and cognitive assessments and a NeuraLight session including oculometric measurements and eye-tracking ...
Eligibility Criteria
Inclusion
- Men and women, age between 40 and 80 years
- \<5 years since disease diagnosis
- Normal or corrected vision
- MOCA score ≥ 20
- Ability to follow instructions
- Willing and able to sign an informed consent form Specific
- PD cohort: Ages 50-80, Hoehn \& Yahr scale 1-3
- PSP cohort: diagnosed according to actual diagnostic criteria from Höglinger GU et al, 2017.
- MSA cohort: diagnosed according to actual diagnostic criteria from Wenning et al, 2022.
Exclusion
- \-
Key Trial Info
Start Date :
September 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06597071
Start Date
September 10 2024
End Date
December 1 2025
Last Update
March 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Biomedicina de Sevilla (IBiS)
Seville, Spain